Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer

Biotechnology Advances

Volumn 32, Issue 6, 2014, Pages 1077-1090

  Adwan, Hassan ^a   Bayer, Helene ^a   Pervaiz, Asim ^a   Sagini, Micah ^a   Berger, Martin R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Antineoplastic activity; Lectin; Ribosome inactivating protein type II; Riproximin; Unfolded protein response; Ximenia americana

Indexed keywords

BINDING SITES; BINS; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; CELLS; CHAINS; CYTOLOGY; CYTOTOXICITY; DISEASES; MACROMOLECULES; POLYSACCHARIDES;

ANTINEOPLASTIC ACTIVITY; LECTIN; RIPROXIMIN; TYPE II; UNFOLDED PROTEIN RESPONSE; XIMENIA AMERICANA;

PROTEINS;

RATTUS; RODENTIA; XIMENIA AMERICANA;

ANTINEOPLASTIC AGENT; RIBOSOME INACTIVATING PROTEIN 2; RIPROXIMIN PROTEIN, XIMENIA AMERICANA; VEGETABLE PROTEIN;

ANIMAL; CHEMISTRY; HUMAN; MOUSE; OLACACEAE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; MICE; OLACACEAE; PLANT PROTEINS; RIBOSOME INACTIVATING PROTEINS, TYPE 2;

EID: 84926259268     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.03.008     Document Type: Review

References (40)

1. Asres K., Bucar F., Kartnig T., Witvrouw M., Pannecouque C., De Clercq E. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytother Res 2001, 15:62-69.
2. Bagga S., Seth D., Batra J.K. The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 2003, 278:4813-4820.
3. Barbieri L., Ciani M., Girbes T., Liu W.Y., Van Damme E.J., Peumans W.J., et al. Enzymatic activity of toxic and non-toxic type 2 ribosome-inactivating proteins. FEBS Lett 2004, 563:219-222.
4. Battelli M.G., Citores L., Buonamici L., Ferreras J.M., de Benito F.M., Stirpe F., et al. Toxicity and cytotoxicity of nigrin b, a two-chain ribosome-inactivating protein from Sambucus nigra: comparison with ricin. Arch Toxicol 1997, 71:360-364.
5. Bayer H., Essig K., Stanzel S., Frank M., Gildersleeve J.C., Berger M.R., et al. Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. J Biol Chem 2012, 287:35873-35886.
6. Bayer H., Ey N., Wattenberg A., Voss C., Berger M.R. Purification and characterization of riproximin from Ximenia americana fruit kernels. Protein Expr Purif 2012, 82:97-105.
7. Burkill H.M., Dalziel John McEwen The useful plants of west tropical Africa, families M-R 1997, Royal Botanic Gardens, Kew. 2nd ed.
8. de Virgilio M., Lombardi A., Caliandro R., Fabbrini M.S. Ribosome-inactivating proteins: from plant defense to tumor attack. Toxins 2010, 2:2699-2737.
9. Diallo D., Sogn C., Samake F.B., Paulsen B.S., Michaelsen T.E., Keita A. Wound healing plants in Mali, the Bamako region. An ethnobotanical survey and complement fixation of water extracts from selected plants. Pharm Biol 2002, 40:117-128.
10. Endo Y., Tsurugi K. Rna N-glycosidase activity of ricin a-chain - mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987, 262:8128-8130.
11. Fong W.P., Mock W.Y., Ng T.B. Intrinsic ribonuclease activities in ribonuclease and ribosome-inactivating proteins from the seeds of bitter gourd. Int J Biochem Cell Biol 2000, 32:571-577.
12. Girbes T., Ferreras J.M., Arias F.J., Stirpe F. Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria. Mini Rev Med Chem 2004, 4:461-476.
13. Griffiths G.D. Understanding ricin from a defensive viewpoint. Toxins 2011, 3:1373-1392.
14. Gronhaug T.E., Glaeserud S., Skogsrud M., Ballo N., Bah S., Diallo D., et al. Ethnopharmacological survey of six medicinal plants from Mali. West Afr J Ethnobiol Ethnomed 2008, 4:26.
15. Gupta P., Walter M.R., Su Z.Z., Lebedeva I.V., Emdad L., Randolph A., et al. BIP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 2006, 66:8182-8191.
16. Hartley M.R., Lord J.M. Cytotoxic ribosome-inactivating lectins from plants. BBA 2004, 1701:1-14.
17. He W.J., Liu W.Y. Cinnamomin: a multifunctional type II ribosome-inactivating protein. Int J Biochem Cell Biol 2003, 35:1021-1027.
18. Horrix C., Raviv Z., Flescher E., Voss C., Berger M.R. Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells. Cell Mol Life Sci 2011, 68:1269-1281.
19. Inngjerdingen K., Nergard C.S., Diallo D., Mounkoro P.P., Paulsen B.S. An ethnopharmacological survey of plants used for wound healing in Dogonland, Mali, West Africa. J Ethnopharmacol 2004, 92:233-244.
20. Jimenez A., Vazquez D. Plant and fungal protein and glycoprotein toxins inhibiting eukaryote protein-synthesis. Annu Rev Microbiol 1985, 39:649-672.
21. Knight B. Ricin - a potent homicidal poison. Br Med J 1979, 1:350-351.
22. Kone W.M., Atindehou K.K., Terreaux C., Hostettmann K., Traore D., Dosso M. Traditional medicine in north Cote-d'Ivoire: screening of 50 medicinal plants for antibacterial activity. J Ethnopharmacol 2004, 93:43-49.
23. Marshall R.S., D'Avila F., Di Cola A., Traini R., Spano L., Fabbrini M.S., et al. Signal peptide-regulated toxicity of a plant ribosome-inactivating protein during cell stress. Plant J 2011, 65:218-229.
24. May M.J., Hartley M.R., Roberts L.M., Krieg P.A., Osborn R.W., Lord J.M. Ribosome inactivation by ricin A chain: a sensitive method to assess the activity of wild-type and mutant polypeptides. EMBO J 1989, 8:301-308.
25. Narayanan S., Surendranath K., Bora N., Surolia A., Karande A.A. Ribosome inactivating proteins and apoptosis. FEBS Lett 2005, 579:1324-1331.
26. Nielsen K., Boston R.S. Ribosome-inactivating proteins: a plant perspective. Annu Rev Plant Biol 2001, 52:785-816.
27. Omer M.E., Elnima E.I. Antimicrobial activity of Ximenia americana. Fitoterapia 2003, 74:122-126.
28. Peumans W.J., Hao Q., Van Damme E.J.M. Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?. FASEB J 2001, 15:1493-1506.
29. Reyes A.G., Geukens N., Gutschoven P., De Graeve S., De Mot R., Mejia A., et al. The Streptomyces coelicolor genome encodes a type I ribosome-inactivating protein. Microbiol Sgm 2010, 156:3021-3030.
30. Saenger J., Leible M., Seelig M.H., Berger M.R. Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction. J Cancer Res Clin Oncol 2004, 130:203-210.
31. Santana S.S., Gennari-Cardoso M.L., Carvalho F.C., Roque-Barreira M.C., Santiago Ada S., Alvim F.C., et al. Eutirucallin, a RIP-2 type lectin from the latex of Euphorbia tirucalli L. presents proinflammatory properties. PLoS One 2014, 9:e88422.
32. Saxena N., Yadav P., Kumar O. The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci 2013, 135:103-118.
33. Stirpe F. Ribosome-inactivating proteins: from toxins to useful proteins. Toxicon 2013, 67:12-16.
34. Szalai K., Scholl I., Forster-Waldl E., Polito L., Bolognesi A., Untersmayr E., et al. Occupational sensitization to ribosome-inactivating proteins in researchers. Clin Exp Allergy 2005, 35:1354-1360.
35. Tamburrino A., Piro G., Carbone C., Tortora G., Melisi D. Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy. Front Pharmacol 2013, 4:56.
36. Treutlein J., Wink M. Molecular phylogeny of cycads inferred from rbcL sequences. Naturwissenschaften 2002, 89:221-225.
37. Voss C., Eyol E., Berger M.R. Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. Toxicol Appl Pharmacol 2006, 211:177-187.
38. Voss C., Eyol E., Frank M., von der Lieth C.W., Berger M.R. Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J 2006, 20:1194-1196. 10.1096/fj.05-5231fje.
39. Walsh M.J., Dodd J.E., Hautbergue G.M. Ribosome-inactivating proteins: potent poisons and molecular tools. Virulence 2013, 4:774-784.
40. Wittmer A., Khazaie K., Berger M.R. Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metastasis 1999, 17:369-376.